Table 2.

Echocardiographic characteristics in patients with myocarditis at baseline and follow-up (n = 20)

	Baseline	Follow-up	p-value
LVEF, %	57 ± 3	60 ± 5	0.086
Global longitudinal strain, %	-19.1 ± 1.8	-21.8 ± 2.5	0.002
E, cm/s	75 ± 18	71 ± 12	0.366
E/A	1.5 ± 0.4	1.4 ± 0.3	0.400
e‘ septal, cm/s	11.6 ± 3.0	12.1 ± 4.1	0.429
e‘ lateral, cm/s	13.7 ± 3.1	14.2 ± 4.5	0.654
E/e‘	6.4 ± 1.6	5.5 ± 1.0	0.038
IVSd, mm	10 ± 2	9 ± 2	0.248
PWd, mm	10 ± 1	9 ± 2	0.181
LVESD, mm	34 ± 4	37 ± 5	0.126
LVEDD, mm	49 ± 4	49 ± 4	0.645
LV mass, g	155 ± 44	144 ± 40	0.160
RVEDD, mm	33 ± 5	34 ± 4	0.754
LAVI, ml/m²	25 ± 9	25 ± 6	0.792
LA area two chamber, cm²	17 ± 5	17 ± 4	0.805
LA area four chamber, cm²	17 ± 4	17 ± 3	0.533
LASr, %	48.3 ± 11.0	49.9 ± 8.1	0.487
LA conduit function, %	-32.7 ± 10.4	-35.0 ± 9.4	0.225
LA booster function, %	-15.6 ± 6.5	-15.0 ± 6.0	0.704
LA stiffness index	0.15 ± 0.07	0.12 ± 0.04	0.080
LA filling index	1.68 ± 0.56	1.47 ± 0.24	0.153
LAVI/LA reservoir function	0.51 (0.40–0.62)	0.54 (0.35–0.62)	0.350

Variables with normal distribution are expressed as mean ± SD, variables with skewed distribution as median (IQR). Median time from baseline to follow-up was 14 (10–24) weeks

LASr LA reservoir function